Manali Petrochemicals Reports FY25 Profit of ₹7,002 Lakh on Consolidated Basis, Recommends Dividend

1747140286957.webp


CHENNAI, May 13 – Manali Petrochemicals Limited (BSE: 500268, NSE: MANALIPETC) reported a consolidated net profit of ₹7,002 lakh for the financial year ended March 31, 2025, marking a 37% increase over ₹5,106 lakh recorded in the previous year. The Board of Directors has recommended a final dividend of ₹0.50 per equity share, subject to shareholder approval at the upcoming Annual General Meeting.

Financial Highlights (₹ in Lakh)​

ParticularsQ4 FY25Q4 FY24FY25FY24
Consolidated Revenue from Ops21,22619,24680,45188,261
Consolidated Total Income23,34420,48987,89893,926
Consolidated Profit Before Tax4,6582,0679,3306,618
Consolidated Net Profit3,1621,4487,0025,106
Standalone Revenue from Ops15,32714,06460,08670,147
Standalone Net Profit6203441,6922,329
EPS (₹) – Consolidated1.910.884.233.09
EPS (₹) – Standalone0.370.211.011.39

Operational Challenges​

Cyclone Michaung disrupted operations at Unit-II during FY25, damaging assets and inventory. The company has accounted for ₹1,870 lakh in repair and restoration costs, with ₹300 lakh received as an interim insurance settlement. The remaining claim is under evaluation.
Additionally, the lease for Unit-II, which expired in June 2017, is still pending renewal from the Government of Tamil Nadu. The company continues to operate the facility and has accounted for the lease under a 30-year extension assumption in compliance with Ind AS 116.

Subsidiary Performance​

The company’s global subsidiaries in Singapore, the UK, Germany, and India significantly drove growth. Profit contributions from international operations totaled ₹5,829 lakh during the year, underscoring the strength of its overseas business model.

Shareholder Actions​

  • Dividend: Final dividend of ₹0.50 per share on a face value of ₹5 each.
  • Postal Ballot: Approval to be sought for payment of remuneration to non-executive directors for FY25.

Strategic Outlook​

Manali Petrochemicals remains well-positioned for growth with a strong international portfolio and a gradual recovery in domestic operations. The company aims to focus on specialty chemical development, operational resilience, and expanding its global footprint in the coming fiscal year.
 
Back
Top